Global Enteral Stents Market: Overview
Enteral stents are deployed in the colon, stomach, and the small bowel. The malignant luminal obstruction of the gastrointestinal tract is treated by the enteral stents. Not only the enteral stents can be used for palliation of malignant obstruction but also they can be used within the colon as a pre operative modality. Enteral stents retain the lumen of the vessels, hollow organs, and ducts. For colonic stents, the pre operative stenting permits a one-stage operation and avoids a colostomy. The surgery can be avoided in the patients that are undergoing palliation of obstruction with the help of the self-expandable metal stents.
Global Enteral Stents Market: Segmentation
The global market for enteral stents is fragmented into product type, material type, and end user. Based on the product type, the global market is segregated into gastroduodenal stents, esophageal stents, and colon stents. Based on the material type, the market is categorized into self-expandable plastic stents and self-expandable metal stents. Based on the end user, the market is bifurcated into specialty clinics, hospitals, ambulatory surgical centers, and others.
Global Enteral Stents Market: Growth Factors
The factors that are driving the enteral stents market are the increasing use of stents in the non-malignant applications, the rise in the need for the effective therapies that will reduce the risk of the complications, increasing use of the removable and fully-covered metal stents in the gastrointestinal applications, the technological advancements that are made in the stent technology with regards to delivery systems and stent design, increasing inclination towards the use of minimally-invasive techniques, and the increasing awareness among the patients are some of the factors that are driving the growth of enteral stents market. However, there are some unmet needs related to the products that are hampering the growth of the enteral stents market.
Global Enteral Stents Market: Regional Analysis
Regional diversification of the enteral stents market is given as follows Latin America, the Middle East & Africa, Western Europe, Eastern Europe, North America, and Asia Pacific. Currently, North America is dominating the enteral stents market. The factors that are contributing to the market growth in the North American region are increasing cases of cancer, technological advancement, changing lifestyle, and fast adoption of the early treatment. The second place in the enteral stents market is held by Europe. In the coming years, Asia Pacific region will have a rapid market growth. Factors that are supporting the market growth in Asia Pacific region are increasing growth in the population, advancements in the healthcare infrastructure, increasing per capita expenditure, and the increasing research and development. The market will have increasing opportunities in the Latin America and the Middle East & Africa regions owing to increasing consumption of alcohol, increasing investment by key manufacturers, health care insurance coverage by the private and government firms, and the growing awareness among people.
Global Enteral Stents Market: Competitive Players
The key market players that are involved in the enteral stents market include B. Braun Melsungen AG, Boston Scientific Corporation, C. R. Bard, Medtronic, Inc., Taewoong Medical, Abbott Vascular, Biosensors International, Cook Medical, Cordis Corporation, Stryker Corporation, and Terumo Corporation.
Global Enteral Stents Market: Regional Segment Analysis
What Reports Provides